Literature DB >> 9186831

Auxiliary partial orthotopic liver transplantation for acute liver failure.

S P Pereira1, M McCarthy, A J Ellis, J Wendon, B Portmann, M Rela, N Heaton, R Williams.   

Abstract

BACKGROUND/AIMS: Auxiliary partial orthotopic liver transplantation holds potential advantages over conventional orthotopic liver transplantation, but experience with the technique in acute liver failure is limited.
METHODS: We describe our initial experience in seven patients (4 men, 3 women; mean age 28, range 14-35 years) with acute liver failure (paracetamol 3, non A-E 2, autoimmune 1, Ecstasy 1) who fulfilled criteria for emergency transplantation. Preoperatively, the median international normalised ratio was seven (range 3.4-15), with a creatinine of 123 microM (51-389 microM) and bilirubin 320 microM (61-572 microM). The reasons for performing an auxiliary transplant were the patients' young age and stable preoperative condition (n = 5), or a significant psychiatric history precluding conventional transplantation (n = 2).
RESULTS: All patients received blood group-matched left (n = 2) or right (n = 5) auxiliary grafts. Median duration of surgery was 8.5 h (7.3-10 h), with blood loss of 8.3 litres (4.6-14.6 litres). Post-transplant, the international normalised ratio and aspartate aminotransferase fell progressively in all patients, with median values at day 7 of 1.4 (1.0-2.4) and 108 IU/1 (78-910 IU/1). Three patients died from sepsis within the first postoperative month. At 2 weeks, four of six patients had partial regeneration of the native liver, which became complete in two of the survivors by 1 year.
CONCLUSIONS: Although patient selection remains poorly defined, auxiliary partial orthotopic liver transplantation in acute liver failure is technically feasible and, in some patients, allows native liver regeneration and eventual immunosuppression withdrawal.

Entities:  

Mesh:

Year:  1997        PMID: 9186831     DOI: 10.1016/s0168-8278(97)80109-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Postoperative imaging findings in children with auxiliary partial orthotopic liver transplant (APOLT).

Authors:  Rama S Ayyala; Mercedes Martinez; Steven J Lobritto; Tomoaki Kato; Carrie Ruzal-Shapiro
Journal:  Pediatr Radiol       Date:  2016-02-11

2.  Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study.

Authors:  D Azoulay; D Samuel; P Ichai; D Castaing; F Saliba; R Adam; E Savier; M Danaoui; A Smail; V Delvart; V Karam; H Bismuth
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 3.  Hepatocyte transplantation for liver-based metabolic disorders.

Authors:  Anil Dhawan; Ragai R Mitry; Robin D Hughes
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 4.  Liver transplantation in children.

Authors:  Mohamed Rela; Anil Dhawan
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

5.  Auxiliary liver transplantation for acute liver failure.

Authors:  J Belghiti; D Sommacale; F Dondéro; F Zinzindohoué; A Sauvanet; F Durand
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

6.  Clinical applications of hepatocyte transplantation.

Authors:  Giada Pietrosi; Giovanni Battista Vizzini; Salvatore Gruttadauria; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

Review 7.  Hepatocyte transplantation for metabolic liver disease: UK experience.

Authors:  Robin D Hughes; Ragai R Mitry; Anil Dhawan
Journal:  J R Soc Med       Date:  2005-08       Impact factor: 18.000

8.  Anaesthetic considerations for liver transplantation in propionic acidemia.

Authors:  Akila Rajakumar; Ilankumaran Kaliamoorthy; Mettu Srinivas Reddy; Mohamed Rela
Journal:  Indian J Anaesth       Date:  2016-01

9.  Clinical and histologic outcome in a dog surviving massive hepatic necrosis.

Authors:  Peter H Kook; Miriam Baumstark; Maja Ruetten
Journal:  J Vet Intern Med       Date:  2018-12-21       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.